GlaxoSmithKline PLC ADR

Yahoo Finance • 11 hours ago

C3 AI Announces Fiscal Second Quarter 2026 Results

Revenue increases 7% QoQ as Federal bookings grow 89%YoY REDWOOD CITY, Calif., December 03, 2025--(BUSINESS WIRE)--C3.ai, Inc. ("C3 AI," "C3," or the "Company") (NYSE: AI), the Enterprise AI application software company, today announced f... Full story

Yahoo Finance • 2 days ago

CDC vaccine panel set to debate hepatitis b shots, childhood immunizations

Elijah Nouvelage/Getty Images News A two-day meeting of the CDC's influential Advisory Committee on Immunization Practices set for December 4-5 will discuss continuing to give newborn babies hepatitis b shots as well as examine the childh... Full story

Yahoo Finance • 2 days ago

FDA top drugs official Pazdur retiring shortly after starting - report

[Headquarters of US Food and Drug Administration (FDA)] Grandbrothers * Less than a month after taking the role, Richard Pazdur, the director of the US FDA's Center for Drug Evaluation and Research, has turned in his resignation papers,... Full story

Yahoo Finance • 2 days ago

Pharma bosses and ministers to shape future drug pricing regime

Some of the global pharmaceutical industry's top executives are to form a new panel with the government aimed at devising a new pricing regime for key medicines. Sky News understands that Whitehall officials and ministers will invite boss... Full story

Yahoo Finance • 2 days ago

Vaccine stocks brace for shock waves at this week’s ACIP meeting

Investing.com -- Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna. The meeting, held Dec.... Full story

Yahoo Finance • 3 days ago

UK to pay 25% more for new drugs under deal with US

[Pile of different colourful pills placed next to 20 British pound banknotes.] Oleksandr Siedov An agreement in principle reached between UK and US trade negotiators will have the latter's National Health Service pay 25% higher list price... Full story

Yahoo Finance • 8 days ago

CMS unveils price reductions for 15 drugs for 2027

[Pills and money] txking/iStock via Getty Images Individuals covered under Medicare can expect significant savings on the 15 drugs that were selected earlier this year for drug price negotiations under the Inflation Reduction Act starting... Full story

Yahoo Finance • 9 days ago

Vaccine critic selected as CDC deputy director

[CDC Headquarters] hapabapa Ralph Abraham, Louisiana's surgeon general, is the CDC's next deputy director. _The Washington Post_, which broke [https://www.washingtonpost.com/health/2025/11/25/cdc-new-deputy-vaccine-ralph-abraham/] the de... Full story

Yahoo Finance • 9 days ago

US, UK nearing drug prices deal - report

[United States of America and United Kingdom Flags. 3d Rendering] klenger/iStock via Getty Images * The US and UK governments are said to be close to a deal that would boost prices of prescription drugs in the UK in exchange for avoidin... Full story

Yahoo Finance • 9 days ago

PD-1 Resistant Head and Neck Cancer Market Research Report 2025-2030: Cracking the Code of Immunotherapy Resistance - How Sox9 and Anxa1 Shape the Tumor-Immune Standoff

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for PD-1 Resistant Head and Neck Can... Full story

Yahoo Finance • 9 days ago

BofA upgrades Novartis and GSK as pivotal data, new launches approach

Investing.com -- Bank of America (BofA) has turned more constructive on two of Europe’s largest drugmakers, upgrading Novartis to Buy and GSK to Neutral as both companies approach a heavy year of product launches and pivotal readouts that... Full story

Yahoo Finance • 10 days ago

Top pharmaceutical stocks by Quant to focus on as Novo Nordisk slides

[Close-up of a male hand holding a pill bottle pouring medication into his hand] Trevor Williams The recent news [https://seekingalpha.com/news/4525254-novo-nordisk-slides-as-ozempic-pill-fails-to-slow-alzheimers-disease-progression-in-la... Full story

Yahoo Finance • 10 days ago

Urinary Tract Infection Treatment Market Competitor Analysis Report 2025: Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue

Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Urinary Tract Infection Treatment Market, Forecast by Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue" report has b... Full story

Yahoo Finance • 10 days ago

CureVac Q3 Earnings Decline

(RTTNews) - CureVac N.V. (CVAC), a biotech company, Monday reported lower earnings and revenue for the third quarter compared to the same period last year. Quarterly earnings decreased to 273.2 million euro or 1.21 euro per share from 338... Full story

Yahoo Finance • 12 days ago

Washington state resident dies from bird flu strain never before detected in humans

[Bird Flu Quarantine Tape Barrier Before Defocused Background] MicroStockHub The Washington State Department of Health has announced that H5N5, a bird flu strain that has never been detected in humans globally, led to the death of an olde... Full story

Yahoo Finance • 13 days ago

AnaptysBio drops as litigation with GSK unit risks cancer therapy deal

Evelyn Mccarthy/E+ via Getty Images AnaptysBio (ANAB [https://seekingalpha.com/symbol/ANAB]) shares lost ~11% in the premarket on Friday after the U.S. drugmaker and its partner Tesaro, a subsidiary of GSK (GSK [https://seekingalpha.com/s... Full story

Yahoo Finance • 13 days ago

TESARO Pursues Litigation Against AnaptysBio For Alleged Material Breach Of Jemperli Agreement

(RTTNews) - GSK plc.'s (GSK) subsidiary TESARO Inc. has commenced litigation against AnaptysBio Inc. (ANAB), contending that AnaptysBio has materially violated the terms of their licensing agreement related to the oncology drug Jemperli.... Full story

Yahoo Finance • 13 days ago

Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

SAN DIEGO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced it has filed a Verified Complaint in Delaware Chance... Full story

Yahoo Finance • 13 days ago

GSK's Tesaro Sues AnaptysBio Over Jemperli License Dispute

(RTTNews) - GSK plc (GSK), a biopharmaceutical company's subsidiary Tesaro, Inc. (TSRO), on Friday announced that it has filed litigation in the Delaware Chancery Court against AnaptysBio, Inc. (ANAB), alleging a material breach of their l... Full story

Yahoo Finance • 15 days ago

Consumer Healthcare Market Size to Surpass USD 588.68 Billion by 2032 Fueled by Rising Self Care Trends and Strong Growth of Digital Health Platforms – SNS Insider

Austin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Consumer Healthcare Market Size and Growth Outlook According to SNS Insider, the global Consumer Healthcare Market reached USD 302.87 billion in 2023 and is projected to surpass USD 588.68 billi... Full story